Nutex Health (NUTX) Depreciation & Amortization (CF) (2010 - 2026)

Nutex Health has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $5.5 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 7.86% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.9 million (up 5.29% YoY) and the FY2025 annual result came in at $20.5 million, up 8.21% from the prior year.
• Depreciation & Amortization (CF) climbed to $5.5 million in Q1 2026 per NUTX's latest filing, from $5.2 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $5.5 million in Q1 2026 and troughed at $2.4 million in Q1 2022.
• A 5-year average of $4.5 million and a median of $4.7 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• The widest YoY moves for Depreciation & Amortization (CF): up 227306.17% in 2022, down 21.7% in 2022.
• Over 5 years, Depreciation & Amortization (CF) stood at $3.3 million in 2022, then surged by 43.13% to $4.7 million in 2023, then increased by 12.77% to $5.3 million in 2024, then decreased by 1.78% to $5.2 million in 2025, then increased by 5.88% to $5.5 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $5.5 million, $5.2 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.